Table 2.
Association between stigma and engagement in HIV care among 306 HIV-positive women who inject drugs participants, Kyiv, Ukraine, November 2019–November 2020
| OR (95% CI) | aOR (95% CI) | |
|---|---|---|
| Internalized stigma | ||
| Neither stigma in both categories | Reference | Reference |
| Drug use stigma only | 0.44 (0.21, 0.91)*** | 0.40 (0.18, 0.89)* |
| HIV stigma only | 0.57 (0.24, 1.36) | 0.79 (0.32, 1.97) |
| Both drug use and HIV status | 0.38 (0.22, 0.65)*** | 0.54 (0.31, 0.95)* |
| Enacted Stigma | ||
| Neither stigma in both categories | Reference | Reference |
| Drug use stigma only | 0.57 (0.30, 1.07) | 0.49 (0.24, 0.98)* |
| HIV stigma only | –a | –a |
| Both drug use and HIV status | 0.51 (0.27, 0.96)* | 0.44 (0.21, 0.89)* |
| Age | ||
| Less than 34 years | Reference | Reference |
| 34 years or older | 1.49 (0.95, 2.34)* | 1.13 (0.68, 1.88) |
| Has any children | ||
| No | Reference | Reference |
| Yes | 1.65 (1.02, 2.66)* | 1.58 (0.94, 2.66) |
| Time since HIV diagnosis | ||
| Less than 5 years | Reference | Reference |
| 5 years or more | 2.25 (1.42, 3.57)** | 2.31 (1.36, 3.94)* |
| Injects drugs almost daily or more | ||
| No | Reference | Reference |
| Yes | 0.68 (0.43, 1.08) | 0.72 (0.44, 1.18) |
*p < 0.05, **p < 0.01, ***p < 0.001
aOdds ratios not calculated for enacted HIV stigma group due to small cell sizes